JournalsHub
.online
Find My Journal
OD

Odette Dos-Santos

Sanofi (France) FR

13
Publications
382
Citations
3
H-Index
3
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

13 total

Abstract 5635: In vivo assessment of a potent TEAD inhibitor in a panel of malignant mesothelioma PDX model

Loreley Calvet, Odette Dos-Santos, Emmanuel Spanakis, Anne Caron, Laurence Noblet et al. - Cancer Research, 2025
Cited by 0 OpenAlex

TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC PDF

Salvina Laura Tammaccaro, Philippe Prigent, Jean-Christophe Le Bail, Odette Dos-Santos, Laurent Dassencourt et al. - Pharmaceuticals, 2023
Cited by 17 OpenAlex

Abstract 3367: Tumor-derived Extracellular Vesicles as a potential PD biomarker for TEAD central pocket binder activity in liquid biopsy

Manoel Nunes, Emmanuel Spanakis, Wilson Dos-Santos-Bele, Emilia Rabia, Stéphane Soubigou et al. - Cancer Research, 2023
Cited by 0 OpenAlex

YAP1 is essential for malignant mesothelioma tumor maintenance PDF

Loreley Calvet, Odette Dos-Santos, Emmanuel Spanakis, Véronique Jean‐Baptiste, Jean-Christophe Le Bail et al. - BMC Cancer, 2022
Cited by 21 OpenAlex

Snacks ́s characteristics and functional components for young and adult consumers in Metropolitan Lima OA

O. Santos, L. Davila, Tarsila Tuesta, Luz Eufemia López Ráez - Agroindustrial science, 2022
Cited by 0 Semantic Scholar

Clinical applicability of Nursing interventions from a given terminology for the assistance provided in the breastfeeding process

O. Santos, Fernanda Broering Gomes Torres, Denilsen Carvalho Gomes, C. C. Primo, Márcia Regina Cubas - Unknown Venue, 2022
Cited by 7 Semantic Scholar

SAR405838: An Optimized Inhibitor of MDM2–p53 Interaction That Induces Complete and Durable Tumor Regression PDF

Shaomeng Wang, Wei Sun, Yujun Zhao, Donna McEachern, Isabelle Meaux et al. - Cancer Research, 2014
Cited by 337 OpenAlex

1017 Human Dedifferentiated Liposarcomas Growth Inhibition by SAR299155, a Potent and Selective Disruptor of the MDM2-p53 Interaction PDF

Odette Dos-Santos, P. Lagarde, Gaëlle Pérot, Frédéric Chibon, Nathalie Ratet et al. - European Journal of Cancer, 2012
Cited by 3 OpenAlex

Abstract 4648: In vitro characterization of spiro-oxindole-based modulators of the MDM2-p53 interaction and their interspecies selectivity.

Christine Delaisi, Isabelle Meaux, Odette Dos-Santos, Cédric Barrière, Francis Duffieux et al. - Cancer Research, 2012
Cited by 1 OpenAlex

Abstract LB-204: Highly potent and optimized small-molecule inhibitors of MDM2 achieve complete tumor regression in animal models of solid tumors and leukemia.

Shaomeng Wang, Wei Sun, Shanghai Yu, Yujun Zhao, Sanjeev Kumar et al. - Cancer Research, 2011
Cited by 3 OpenAlex

Research Topics

Cancer-related Molecular Pathways (10) Hippo pathway signaling and YAP/TAZ (3) Ubiquitin and proteasome pathways (2) Cancer Research and Treatments (2) Cellular Mechanics and Interactions (1)

Affiliations

University of Wolverhampton
GB 2012 - 2012
University of Parma
IT 2012 - 2012
Queen's University
CA 2012 - 2012
Sanofi (France)
FR 2025 - 2012
Celon Pharma (Poland)
PL 2012 - 2012

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now